🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Immune Deficiency

Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage NCT05939167Phase 1, Phase 24 sites📍 Beijing📍 Beijing📍 Shenzhen Cell Energy Life Sciences Group Co. LTD · Tests: mesenchymal stem cell, saline Missed Opportunities for HIV Screening in General Practice NCT07303114n/a1 site📍 Strasbourg University Hospital, Strasbourg, France DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road) NCT06034938Phase 24 sites📍 Caen📍 Orléans📍 Rouen University Hospital, Caen · Tests: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO] Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy NCT07336797Phase 21 site📍 Cairo Abdelrahman Mahmoud · Tests: Empagliflozin (oral), Placebo A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment NCT07393659Phase 34 sites📍 Durban📍 Jouberton📍 Gauteng ViiV Healthcare · Tests: Fostemsavir, Dolutegravir (DTG)/ Lamivudine (3TC) Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals NCT06805656Phase 21 site📍 São Paulo Federal University of São Paulo · Tests: Maraviroc, Dolutegravir, Dendritic Cell Vaccine, Auranofin, Sirtuin Histone deacetylase inhibitor Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health NCT06796686Phase 16 sites📍 San Francisco📍 Atlanta📍 Decatur National Institute of Allergy and Infectious Diseases (NIAI… · Tests: 426c.Mod.Core-C4b, HxB2.WT.Core-C4b, 3M-052-AF adjuvant, Aluminum hydroxide suspension (Alum) adjuvant, Diluent Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers NCT06580574Phase 21 site📍 Beijing Peking University · Tests: PD1/PDL1 antibody monotherapy, up to 24 weeks, Intensive immunotherapy plus anti-VEGF treatment, up to 24 weeks, Radica… Human Immunodeficiency Virus (HIV) Food Insecurities NCT04943861NA1 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: weCare/Secure, Usual Care Vienna HIV Infection Via Sex Study NCT05326061n/a1 site📍 Vienna Medical University of Vienna A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome NCT05027945Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Allogeneic HSCT, Busulfan test dose, Mycophenolate mofetil (MMF), Tacrolimus, Busulfan Texting to Reduce Human Immunodeficiency Virus (HIV) Risk NCT06088277NA2 sites📍 Boston📍 Boston Boston University · Tests: TM HIV, TM HL Cardiovascular Responses to Exercise in People Living With HIV/AIDS: Effects of Exercise Training NCT04512456NA1 site📍 Rio de Janeiro Instituto Nacional de Cardiologia de Laranjeiras · Tests: Exercise training Feasibility of HPV Testing With Mail-delivered Sample Collection Kits NCT07087145n/a1 site📍 San Francisco University of California, San Francisco · Tests: Mail-based Saliva Sample Kit, Study-related Surveys Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH) NCT06501781NA2 sites📍 Washington D.C.📍 Baltimore University of Maryland, Baltimore · Tests: Peer Activate-LAI, Standard of Care HIV treatment or prevention with LAI-PrEP/ART Platelets Target the Circulating HIV Reservoir: Implications for Immunological Failure NCT07745530n/a1 site📍 Tourcoing Tourcoing Hospital · Tests: blood sampling Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184 NCT07636928Phase 11 site📍 Groningen ViiV Healthcare · Tests: VH4524184, [14C]VH4524184 microdose, [14C]VH4524184 A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) NCT07202546Phase 2123 sites📍 Bakersfield📍 Palm Springs📍 West Hollywood ViiV Healthcare · Tests: VH4524184, Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tablets, Dolutegravir / Lam… Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer NCT06613165n/a1 site📍 Xi'an Xijing Hospital The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen NCT01890486n/a1 site📍 Winston-Salem Wake Forest University Health Sciences Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART) NCT06541028NA3 sites📍 Kajang📍 Kuala Lumpur📍 Kuala Lumpur Yale University · Tests: Rapid-Start ART (RS-ART) Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma NCT05077527Phase 17 sites📍 Duarte📍 Chicago📍 New York AIDS Malignancy Consortium · Tests: Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine The Experience of Screening for SCID NCT05651113n/a1 site📍 London King's College London · Tests: SCID Screening Online Cohort of Sexual and Gender Minorities: Evaluating Digital Interventions to Improve HIV Pre-Exposure Prophylaxis and Antiretroviral Treatment Uptake and Adherence NCT07772791NA1 site📍 Rio de Janeiro Oswaldo Cruz Foundation · Tests: Weekly WhatsApp Adherence Messages Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes NCT05642715NA1 site📍 The Bronx Montefiore Medical Center · Tests: EX+, Varenicline, HR, TAU Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention NCT07076043Phase 41 site📍 Thika University of Alabama at Birmingham · Tests: Multiple Product PrEP Program, Routine Oral PrEP Efficacy of mHealth + e-Navigator Stepped Care Intervention for ART Adherence Among Latino Men With HIV NCT06375135NA1 site📍 Miami Florida International University · Tests: TXTXT, e-Navigation, Ecological Momentary Assessment (EMA) supported e-Navigation. Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies NCT07648264Phase 360 sites📍 Orange📍 Denver📍 Coral Springs CSL Behring · Tests: IgPro20 Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) NCT04197596Phase 1, Phase 27 sites📍 San Francisco📍 Baltimore📍 St Louis New York Medical College · Tests: BK CTL Reducing Mortality in Adults With Advanced HIV Disease (REVIVE) NCT05580666Phase 352 sites📍 Abidjan📍 Abidjan📍 Abidjan Population Health Research Institute · Tests: Azithromycin Oral Tablet, Placebo oral tablet
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy